#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16672	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2178	758.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1658	1658	T	883	T	820	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16672	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2178	758.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1392	1392	C	941	C,T	902,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30110	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3696	812.7	0	.	n	.	0	T695C	SNP	695	695	T	1090	1090	C	902	C	858	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30110	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3696	812.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1732	1732	A	990	A	950	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30110	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3696	812.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2366	2366	C	986	C	935	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30110	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3696	812.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2440	2440	A	948	A	913	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30110	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3696	812.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2992	2992	C	914	C	878	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2238	folP	855	855	100.0	folP.l15.c30.ctg.1	1693	132.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1085	1087	AGC	219;218;214	A;G;C	211;210;207	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5818	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3393	170.9	1	SNP	p	S91F	1	.	.	271	273	TTC	590	592	TTC	184;187;192	T;T,C;C	174;176,1;176	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5818	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3393	170.9	1	SNP	p	D95G	1	.	.	283	285	GGC	602	604	GGC	193;193;192	G,A;G,A;C,A	178,1;179,1;178,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5818	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3393	170.9	1	SNP	p	G95N	0	.	.	283	285	GGC	602	604	GGC	193;193;192	G,A;G,A;C,A	178,1;179,1;178,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1936	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1384	139.3	1	SNP	p	G45D	0	.	.	133	135	GGC	547	549	GGC	251;248;252	G;G;C	238;238;239	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	928	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1169	79.0	0	.	n	.	0	A197.	DEL	197	197	A	738	738	A	205	A	197	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3211	186.0	1	SNP	p	D86N	0	.	.	256	258	GAC	644	646	GAC	249;250;248	G;A;C	233;226;233	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3211	186.0	1	SNP	p	S87R	1	.	.	259	261	CGT	647	649	CGT	250;251;253	C;G,A;T	237;233,1;234	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3211	186.0	1	SNP	p	R87W	0	.	.	259	261	CGT	647	649	CGT	250;251;253	C;G,A;T	237;233,1;234	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3211	186.0	1	SNP	p	R87I	0	.	.	259	261	CGT	647	649	CGT	250;251;253	C;G,A;T	237;233,1;234	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3211	186.0	1	SNP	p	S88P	0	.	.	262	264	TCC	650	652	TCC	250;248;248	T;C;C	231;231;237	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4752	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2680	176.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1605	1607	GGC	238;237;231	G;G;C,A	228;226;217,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4512	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2325	192.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1210	1212	GCA	234;238;240	G;C;A	223;225;229	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4512	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2325	192.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1213	1215	ATC	243;240;244	A;T;C	231;228;229	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4512	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2325	192.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1225	1227	GTG	250;251;248	G;T;G	235;232;230	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4512	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2325	192.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1225	1227	GTG	250;251;248	G;T;G	235;232;230	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4512	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2325	192.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1729	1731	ACC	218;218;218	A;C;C	202;199;203	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4512	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2325	192.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1783	1785	GCG	203;204;203	G;C;G	178;162;173	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4512	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2325	192.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1783	1785	GCG	203;204;203	G;C;G	178;162;173	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4512	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2325	192.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1906	1908	AGC	217;214;215	A;G;C	205;202;200	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4512	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2325	192.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1915	1917	GGC	200;198;197	G;G;C	190;187;182	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4512	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2325	192.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1933	1935	CCG	178;178;180	C,G,T;C;G	136,3,1;138;142	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6452	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3121	206.1	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1541	1543	ACG	239;239;237	A;C;G	219;221;220	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6452	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3121	206.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1679	1681	CCG	208;211;208	C;C;G	190;198;192	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2436	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1783	135.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	531	531	C	172	C	158	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3296	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1609	202.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	522	524	GAA	271;271;269	G;A;A	254;253;250	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3296	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1609	202.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	810	812	GAT	278;277;275	G;A;T	261;261;256	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3296	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1609	202.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	933	935	TCA	277;278;277	T;C;A	251;255;254	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3296	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1609	202.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1062	1064	GTC	266;266;265	G;T;C,A	248;250;248,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3296	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1609	202.1	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1074	1076	TCT	268;268;272	T;C;T	253;255;257	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3296	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1609	202.1	0	.	p	.	0	D297G	NONSYN	889	891	GAC	1299	1301	GGC	253;252;251	G,A;G,A;C	241,1;240,1;237	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3296	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1609	202.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1392	1394	GCA	264;264;266	G,A;C;A	247,1;249;251	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3296	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1609	202.1	1	SNP	p	G120K	1	.	.	358	360	AAG	768	770	AAG	245;248;247	A;A;G	238;243;242	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3296	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1609	202.1	1	SNP	p	A121D	1	.	.	361	363	GAC	771	773	GAC	245;244;245	G;A;C	237;238;236	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3296	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1609	202.1	1	SNP	p	D121N	0	.	.	361	363	GAC	771	773	GAC	245;244;245	G;A;C	237;238;236	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11958	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4813	247.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1246	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1113	111.3	1	SNP	p	V57M	1	.	.	169	171	ATG	488	490	ATG	231;233;234	A;T;G	218;220;221	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
